Company intelligence / Profile preview
Torii Pharmaceutical
- Ownership
- Public · 4551
- Employees
- ~592
- Development stage
- Commercial
Overview
Torii Pharmaceutical develops, manufactures, and markets a range of pharmaceutical products including small molecules, biologics, allergen immunotherapies, and topical treatments. The company has commercialized several drugs in Japan across dermatology, nephrology/kidney disease management, allergy/immunology, obstetrics/pediatrics. Recent clinical results include positive bioequivalence data for their JAK inhibitor “JTE‑052” formulations in atopic dermatitis. The company also partners internationally to bring new therapies to the Japanese market.
- Therapeutic areas
- NephrologyImmunologyDermatologyWomen's HealthInfectious Diseases
- Modalities
- Small moleculeBiologicAllergen immunotherapyPeptidesRecombinant protein
- Industry
- Biotech
Drug pipeline
5 assets4 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Torii Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Torii Pharmaceutical.